Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 199.63
-2.27 (-1.12%)
Oct 31, 2025, 3:29 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 265.08 billion as of October 31, 2025. Its market cap has decreased by -9.08% in one year.
Market Cap
265.08B
Enterprise Value
309.56B
Revenue
91.34B
Ranking
n/a
PE Ratio
272.39
Stock Price
199.63
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 265.08B, an increase of 16.91%. That is a compound annual growth rate of 5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 265.08B | -24.90% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.10T |
| Mankind Pharma | 984.02B |
| Zydus Lifesciences | 980.52B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 661.47B |